Global Information
회사소개 | 문의 | 위시리스트

세계의 혈류 전환 동맥류 치료 시장(2018-2022년)

Global Flow Diversion Aneurysm Treatment Market 2018-2022

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2018년 07월 상품 코드 366013
페이지 정보 영문 115 Pages
가격
US $ 2,500 ₩ 3,036,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,643,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,858,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,073,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 혈류 전환 동맥류 치료 시장(2018-2022년) Global Flow Diversion Aneurysm Treatment Market 2018-2022
발행일 : 2018년 07월 페이지 정보 : 영문 115 Pages

혈류 전환 동맥류 치료에 대해

혈류 전환 동맥류 치료는 혈류 전환형 스텐트(FDS) 및 강내 혈류 전환 분단 기기 등 혈관내 기기의 사용으로 구성됩니다. 이러한 기기는 두개내 동맥류(IA)의 치료에 사용되고 있습니다.

Technavio의 애널리스트는 2018-2022년간 세계의 혈류 전환 동맥류 치료 시장이 14%의 연평균 성장률(CAGR)로 성장할 것으로 예측했습니다.

세계의 혈류 전환 동맥류 치료(Flow Diversion Aneurysm Treatment) 시장에 대해 조사 분석했으며, 시장 규모와 성장률, 시장 동향, 시장 성장 촉진요인과 과제, 시장 기회, 주요 벤더 등의 정보를 전해드립니다.

제1장 주요 요약

제2장 조사 범위

제3장 조사 방법

제4장 시장 상황

  • 시장 생태계
  • 시장 특성
  • 시장 세분화 분석

제5장 시장 규모

  • 시장 정의
  • 시장 규모(2017년)
  • 시장 규모 및 예측(2017-2022년)

제6장 Five Forces 분석

  • 구매자의 협상력
  • 공급업체의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 상황

제7장 시장 세분화 : 제품별

  • 세분화 : 제품별
  • 비교 : 제품별
  • FDS
  • 부정확한 혈류 파괴 기기(Intrasaccular Flow Disruption Devices)
  • 시장 기회 : 제품별

제8장 고객 상황

제9장 지역 상황

  • 지역별 세분화
  • 지역 비교
  • 유럽, 중동 및 아프리카
  • 아메리카
  • 아시아태평양
  • 시장 기회

제10장 의사결정 체계

제11장 성장요인과 과제

  • 시장 성장요인
  • 시장 과제

제12장 시장 동향

  • 연구개발 강화
  • 확대하는 적응증

제13장 벤더 상황

  • 개요
  • 창조적 파괴 상황

제14장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Acandis
  • Medtronic
  • Phenox
  • Stryker
  • TERUMO CORPORATION

제15장 부록

  • 약어 리스트
KSM 18.07.30

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

About flow diversion aneurysm treatment

Flow diversion aneurysm treatment consists of the use of endovascular devices such as flow-diverting stents (FDS) and intrasaccular flow disruption devices. These devices are used in the treatment of intracranial aneurysms (IAs).

Technavio's analysts forecast the Global Flow Diversion Aneurysm Treatment Market to grow at a CAGR of 14% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the flow diversion aneurysm treatment market. To calculate the market size, the report considers the revenue generated from the sales of products such as flow-diverting stents (FDS) and intrasaccular flow disruption devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Flow Diversion Aneurysm Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Acandis
  • Medtronic
  • Phenox
  • Stryker

Market driver

  • Increasing prevalence of IAs and associated risk factors
  • For a full, detailed list, view our report

Market challenge

  • Lack of awareness and access to flow diversion procedures in emerging countries
  • For a full, detailed list, view our report

Market trend

  • Increasing R&D focus
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • FDS
  • Intrasaccular flow disruption devices
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Flow diversion aneurysm treatment market in EMEA
  • Flow diversion aneurysm treatment market in Americas
  • Flow diversion aneurysm treatment market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing R&D focus
  • Expanding indications

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Acandis
  • Medtronic
  • Phenox
  • Stryker
  • TERUMO CORPORATION

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global neurovascular devices market
  • Exhibit 02: Global neurovascular devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global flow diversion aneurysm treatment market
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global flow diversion aneurysm treatment market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global flow diversion aneurysm treatment market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global flow diversion aneurysm treatment market - Market share by product 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global FDS market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global FDS market - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global intrasaccular flow disruption devices market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global intrasaccular flow disruption devices market - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global flow diversion aneurysm treatment market - Market share by geography 2017-2022 (%)
  • Exhibit 27: Regional comparison
  • Exhibit 28: Flow diversion aneurysm treatment market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Flow diversion aneurysm treatment market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Top two countries in EMEA
  • Exhibit 31: Flow diversion aneurysm treatment market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 32: Flow diversion aneurysm treatment market in Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Top two countries in Americas
  • Exhibit 34: Flow diversion aneurysm treatment market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 35: Flow diversion aneurysm treatment market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top two countries in APAC
  • Exhibit 37: Market opportunity
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: Acandis - Overview
  • Exhibit 44: Acandis - Product segments
  • Exhibit 45: Acandis - Organizational developments
  • Exhibit 46: Acandis - Geographic focus
  • Exhibit 47: Acandis - Segment focus
  • Exhibit 48: Acandis - Key offerings
  • Exhibit 49: Acandis - Key customers
  • Exhibit 50: Medtronic - Overview
  • Exhibit 51: Medtronic - Business segments
  • Exhibit 52: Medtronic - Organizational developments
  • Exhibit 53: Medtronic - Geographic focus
  • Exhibit 54: Medtronic - Segment focus
  • Exhibit 55: Medtronic - Key offerings
  • Exhibit 56: Medtronic - Key customers
  • Exhibit 57: Phenox - Overview
  • Exhibit 58: Phenox - Product segments
  • Exhibit 59: Phenox - Organizational developments
  • Exhibit 60: Phenox - Geographic focus
  • Exhibit 61: Phenox - Segment focus
  • Exhibit 62: Phenox - Key offerings
  • Exhibit 63: Phenox - Key customers
  • Exhibit 64: Stryker - Overview
  • Exhibit 65: Stryker - Business segments
  • Exhibit 66: Stryker - Organizational developments
  • Exhibit 67: Stryker - Geographic focus
  • Exhibit 68: Stryker - Segment focus
  • Exhibit 69: Stryker - Key offerings
  • Exhibit 70: Stryker - Key customers
  • Exhibit 71: TERUMO CORPORATION - Overview
  • Exhibit 72: TERUMO CORPORATION - Business segments
  • Exhibit 73: TERUMO CORPORATION - Organizational developments
  • Exhibit 74: TERUMO CORPORATION - Geographic focus
  • Exhibit 75: TERUMO CORPORATION - Segment focus
  • Exhibit 76: TERUMO CORPORATION - Key offerings
  • Exhibit 77: TERUMO CORPORATION - Key customers
Back to Top
전화 문의
F A Q